More case studies
Challenge
The client needed to enroll patients within an extremely short timeframe of 6-months. Additionally, due to the global nature of the study, they also required Certificates of Analysis (CoA), making the feasibility of the request extra challenging.
Result
CSI was tasked with sourcing a vast quantity of Venetoclax and Azacitidine for a large pharmaceutical company's global study on Acute Myeloid Leukaemia, covering 17 countries in 3 continents.
Solution
Leveraging CSI's strong partnership with AbbVie and generic manufacturers, we were able to cut the study approval time in half and reduce the supply lead time four-fold, from four months to 4 weeks, including the required documentation. As a result, the client successfully delivered supplies to sites ahead of schedule.
Case Study
Accelerating global AML study: How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time
CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries
Challenge
The client faced a tight six-month enrollment deadline and required Certificates of Analysis (CoA) for a complex study.
Result
CSI was entrusted with sourcing large quantities of Venetoclax and Azacitidine for a study spanning 17 countries three continents.
Solution
CSI utilized its partnerships to halve approval times, reduce supply lead times from four months to four weeks and ensure timely delivery with all required documentation.
Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements
Contact us
.png){kind=logo}